STXS logo

STEREOTAXIS INC

STXSNYSE AMERICAN
๐Ÿ† #3348 by market capEarnings Nov 10US Equity
$1.34โ–ผ $0.11 (โˆ’8.56%)
Live
1hโ–ฒ 0.8%
24hโ–ผ 8.6%
7dโ–ผ 3.3%
14dโ–ฒ 0.4%
30dโ–ผ 18.1%
1yโ–ผ 49.8%
๐ŸฆMarket Cap
$131M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
+20.3%
Healthy
๐Ÿ“ŠGross Margin
55.6%
Healthy
๐Ÿ’ตFCF Margin
-51.6%
Thin
โš–๏ธP/S Ratio
4.8x
Fair
Otter Score
60
Fair

Trading Snapshot

Day Range
$1.31 โ€“ $1.35
52-Week Range
$1.24 โ€“ $3.59
Volume
$4.00B
Avg Volume
$3.61B
Shares Outstanding
97.9M
Next Earnings
Oct 10, 2026

Fundamentals Snapshot

Annual Revenue
$32M
Last Q Revenue
$8M
P/E Ratio
-5.9
P/S Ratio
4.8x
EPS (TTM)
$-0.23
Dividend Yield
0.00%

Why Investors Own STXS

  • โœ“High-growth profile โ€” revenue up +3.5% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 78% gross margin and 22% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$32Mโ–ฒ +2.3% YoY
Gross Margin (TTM)
78.3%โ–ฒ +3.6% YoY
Operating Income (TTM)
$4Mโ–ฒ +2.3% YoY
Free Cash Flow (TTM)
$7Mโ–ฒ +2.3% YoY

About STEREOTAXIS INC

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Fair
60/100

Analyst Ratings

โ“˜
Consensus
Buy
10 analysts
Strong Buy2
Buy7
Hold1
Sell0
Strong Sell0
Ratings as of Aug 2026

Latest News & Updates